Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
MCRB | F | Seres Therapeutics, Inc. | 5.03 | |
LIXT | F | Lixte Biotechnology Holdings, Inc. | 7.24 | |
FBIO | F | Fortress Biotech, Inc. | 2.55 | |
NVAX | F | Novavax, Inc. | 5.35 | |
NKTR | F | Nektar Therapeutics | 3.96 | |
BBIO | F | BridgeBio Pharma, Inc. | 0.77 | |
IMUX | F | Immunic, Inc. | -0.90 | |
NXTC | F | NextCure, Inc. | -7.75 | |
CYTK | F | Cytokinetics, Incorporated | 3.00 | |
CRVO | F | CervoMed Inc. | 0.21 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Biopharmaceutical
Biotechnology
Cancer
Medicine
Acute Myeloid Leukemia
Biology
Bone
Clinical Research
Clinical Trial
Diabetes
Drug Discovery
Immunology
Infectious Diseases
Inflammation
Life Sciences
Monoclonal Antibodies
Monoclonal Antibody
Pain
Pharmacology
Rheumatoid Arthritis
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PBE | C | PowerShares Dynamic Biotech & Genome | 8.96 | |
MNTL | D | Tema Neuroscience and Mental Health ETF | 8.41 | |
FBT | C | First Trust Amex Biotech Index Fund | 6.65 | |
BBH | D | Market Vectors Biotech ETF | 5.55 | |
FCUS | A | Pinnacle Focused Opportunities ETF | 5.32 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Medical Devices
Related Stock Lists:
Medicine
Biopharmaceutical
Central Nervous System Disorders
Nervous System Disorders
Organ Systems
Pain
Autoimmune Disease
Cancer
Depression
Insomnia
Monoclonal Antibodies
Monoclonal Antibody
Oncology
Pulmonology
Rare Diseases
Alcohol
Alzheimer's Disease
Antibodies
Antibody Drug Conjugate
Antidepressants
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles